Dry Needling & Trigger Point Compression Release in Neck Pain

Neck Pain Clinical Trial

Official title:

A Randomized Clinical Trial To Review The Effectiveness Of Dry Needling Versus Trigger Point Compression Release Among Patients With Neck Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05870904
• Other study ID #: 070/BPMI/ Saad Tariq DPT
• Status: Completed
• Phase: N/A
• Start date: June 1, 2021
• Est. completion date: October 31, 2021

Study information

• Verified date: May 2023
• Source: Health Education Research Foundation (HERF)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This randomized control trial was conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points.

Description:

Many treatment protocols have been used in the clinical arena for the improvement of neck pain but un-availability of follow-up studies and lack of evidence of modern treatment interventions are few shortcomings a researcher faces. Thus, a need stands up to address these perspectives for newer treatment strategies. This randomized control trial is conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points. Findings of this research will assist in creating awareness about better treatment intervention for trigger point release among medical community.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: October 31, 2021
• Est. primary completion date: September 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• Patients between the age group of 20 to 40 years.

• Both Male and female patients.

• Patients presenting with neck pain due to MTrP's.

• The presence of a palpable taut band in the neck region.

• Patients reporting typically referred pain pattern of the MTrP in response to compression.

Exclusion Criteria:

• Patients with any associated comorbidities such as hypertension and diabetes.

• Patients with known history of fibromyalgia syndrome, whiplash injury, cervical spine surgery fracture and cervical radiculopathy.

• Patients with any systemic disease such as rheumatism and tuberculosis or cervical myelopathy and multiple sclerosis.

• Patients with history of myofascial trigger point therapy one month prior to enrollment.

• Patients with non-cooperative attitude, fear or any contraindications to needling.

Related Conditions & MeSH terms

• Muscle Tightness
• Myofascial Pain Syndromes
• Neck Muscle Issue
• Neck Pain
• Trigger Point Pain, Myofascial

Intervention

Other:
• Dry Needling
Dry Needling includes the insertion of a fine, strong filiform needle without presentation of any pain relieving medicine. Ischemic pressure is usually applied to trigger point, in what is known as trigger point therapy, where enough continuous pressure is applied to a trigger point within a tolerable measure of pain, and as discomfort is decreased, extra pressure is gradually applied

Locations

Country	Name	City	State
Pakistan	Bashir Institute of Health Sciences,Bashir General & Dental Hospital	Islamabad

Sponsors (1)

Lead Sponsor	Collaborator
Health Education Research Foundation (HERF)

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Pain assessed through Visual Analogue Pain Scale	To measure the change in terms of betterment or aggravation in the intensity of pain baseline then after week 1,week 2 and after week 3.	Data was Collected at Baseline and after week 1,2 & 3.
Primary	Change in degree of disability assessed through Northwick Park Neck Pain Questionnaire.	To measure change in the intensity of neck pain and the consequent patient disabilities at baseline then after week 1,week 2 and after week 3.	Data was Collected at Baseline and after week 1,2 & 3.